Posts tagged with 'outlook'
A ‘Bullish’ Year for IT JobsRead the rest of this entry »
Tech jobs, which took a hit during the first months of the pandemic, are on the rebound and likely to surge this year.
“We’re very bullish on hiring in 2021, particularly in tech,” labor economist Julia Pollak told Crunchbase.
Likewise, Art Zeile, CEO of the company that owns the tech job site Dice.com, said, “We believe that there will be a post-pandemic explosion of interest in technologists, and that …
Banking’s 2021 Outlook: Transformation and ResilienceRead the rest of this entry »
When the pandemic forced the shutdown of businesses across much of the world, one of the sectors that adapted quickly was finance.
In a detailed forward-looking article, Deloitte applauded banking’s response calling it “notable… Banks effectively deployed technology and demonstrated unprecedented agility and resilience.” Looking ahead, the report says now is the time for the industry to institutionalize what it learned about engaging customers, digital transformation, finance and talent, …
Temporary Staffing Jobs In 2028Read the rest of this entry »
We came across an interesting analysis of what the next 10 years of temporary employment may look like. It's based on the biennial 10 year projections of the US Bureau of Labor Statistics.
The government's outlook is that overall non-farm employment will grow by a somewhat anemic 5.6% through 2028. Temporary help services -- temporary workers provided by staffing firms like us -- will grow by 2.3%. These are projections, …
J.P. Morgan Foresees Moderate Growth, No Recession In 2020Read the rest of this entry »
Predicting 2020 "will be a year of moderate global growth and contained inflation, with risks skewed to the downside," J.P. Morgan Asset Management last week released its second annual Global Alternatives Outlook.
The report offers a look across key alternative asset classes over the next year to 18-months, with a focus on hedge funds, private credit, real estate and private equity.
The broad outlook, according to J.P. Morgan, is …
As Pharma Transforms, Drug Stocks Poised for ComebackRead the rest of this entry »
Big Pharma is poised for a financial comeback this year, even as both industry leaders and ambitious upstarts will navigate through choppy waters.
J.P. Morgan analyst Chris Schott wrote in mid-December that 2020 will be a recovery year for the stocks of major pharmaceutical companies. After a year in which the S&P 500 was up 25%, the S&P 500 Pharmaceuticals grew not even half that.
Schott basis his forecast on …
Job Growth 'Slow, But Steady'Read the rest of this entry »
Solid, but slow job growth through the end of the year, is the prediction of the non-profit business group, The Conference Board.
The Board released its monthly Employment Trends Index Monday, which showed a rise of 1.68 from June's 109.3 reading. The Index now stands at 110.98.
“The Employment Trends Index increased in July but continues to hover around a flat trend since the summer of 2018,” said Gad Levanon, …
The 'Next Big Thing' Is DeadRead the rest of this entry »
The “Next Big Thing” is dead, CompTIA declares in its annual IT outlook report. The trade association for the tech industry says the phenomenon of revolutionary products like smartphones is becoming less relevant “in a world defined not by ‘one big thing,’ but rather, the iterative fusion of technology building blocks coupled with a generous helping of people and process.”
That idea underlies the trends the organization believes will …
Q1 Hiring Plans Are Strongest In YearsRead the rest of this entry »
The stock market may be seesawing, but employers are still bullish on hiring. Two recent surveys of hiring intention both pointed to strong plans by employers to add staff in the first quarter of this new year.
Manpower's long running Employment Outlook, based on a survey of 12,500 employers, shows 23% expect to add headcount between now and the end of March. Seasonally adjusted basis that comes out to …
Biotech and Pharma: Outlook Is Overall PositiveRead the rest of this entry »
For the biotech and pharmaceutical industries, 2018 has proven to be a mixed bag, but with more overall positives than negatives.
In an article reviewing the year so far, and looking ahead to 2019, Peter Young president and managing director of the life science and chemicals investment banking firm Young & Partners, says drug approvals and development escalated and the emergence of new approaches in immuno-oncology, CRISPR, personalized medicine, and …
Economic Forecast: Expect Volatility, Above Trend GrowthRead the rest of this entry »
Global growth is expected to be strong -- "above trend," is the exact language -- while in the U.S. "favorable financial conditions and stimulative fiscal policy should support economic momentum."
That's the assessment from J.P. Morgan's Global Fixed Income, Currency & Commodities Investment Quarterly meeting. The report earlier this month raised the "Above Trend Growth" scenario by 5 percentage points to 75% for the current quarter and possibly extending even …